Erudio Healtherudio.com
Clinical trial · no report yet · Phase 3
NEOPAC
Adjuvant Versus Neoadjuvant Plus Adjuvant Chemotherapy in Resectable Pancreatic Cancer
- NCT01314027 ↗
- Terminated
- University of Zurich
- Focused size, estimated: 1–150 verified statements
We haven't built an HCP commentary report on NEOPAC (gemcitabine plus oxaliplatin in resectable pancreatic cancer) yet. This page shows the registry record and the public commentary we found that names the trial. A report reads that commentary and sets out what clinicians said about the trial, each point linked to its source. How reports are made.
Indexed commentary on NEOPAC so far
Podcasts, YouTube videos and X posts we have indexed that name the trial. It is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.
| Indexed so far | |
|---|---|
| 2 posts on X | |
| 1 YouTube video |
The trial
ClinicalTrials.gov- Official title
- Adjuvant Gemcitabine Versus NEOadjuvant Gemcitabine/Oxaliplatin Plus Adjuvant Gemcitabine in Resectable PAncreatic Cancer: a Randomized Multicenter Phase III Study (NEOPAC Study)
- Phase
- Phase 3
- Status
- Terminated
- Conditions
- Pancreatic Cancer
- Interventions
- Neoadjuvant Chemotherapy with gemcitabine/oxaliplatin; adjuvant chemotherapy with gemcitabine
- Arms
- neoadjuvant + adjuvant chemotherapy · Experimental
- adjuvant chemotherapy · Active comparator
- Enrollment
- 38
- Primary outcomes
- Progression-free survival
- Sponsor
- University of Zurich
- Start
- Sep 2009
- Primary completion
- Dec 2018
- Results posted
- No
- Registry record
- NCT01314027 · updated Jul 25, 2019
Publications
linked from the registry- Heinrich S, Pestalozzi B, Lesurtel M, Berrevoet F, Laurent S, Delpero JR, Raoul JL, Bachellier P, Dufour P, Moehler M, Weber A, Lang H, Rogiers X, Clavien PA. Adjuvant gemcitabine versus NEOadjuvant gemcitabine/oxaliplatin plus adjuvant gemcitabine in resectable pancreatic cancer: a randomized multicenter phase III study (NEOPAC study). BMC Cancer. 2011 Aug 10;11:346. doi: 10.1186/1471-2407-11-346. PubMed 21831266